Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy

被引:12
作者
Brenes Sanchez, Juana Maria [1 ]
Lopez Picado, Amanda [2 ]
Olivares Crespo, Maria Eugenia [1 ]
Garcia Saenz, Jose Angel [3 ]
De La Plata Merlo, Rosa Maria [1 ]
Herrera De La Muela, Maria [1 ]
机构
[1] Hosp Clin San Carlos, Womens Hlth Inst, Obstet & Gynecol, Breast Canc Unit, Martin Lagos S-N, Madrid 28040, Spain
[2] Hosp Clin San Carlos, IdISSC, Clin Trials & Res Unit, Madrid, Spain
[3] Hosp Clin San Carlos, Oncol Dept, Breast Canc Unit, Madrid, Spain
关键词
Breast cancer; Quality care; SARS-CoV-2; Surgical strategy; Systemic therapy; ONCOLOGY; SURGERY; THERAPY; MILAN;
D O I
10.1016/j.clbc.2020.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer experts share their experience in the management of surgical strategy for patients with breast cancer during the COVID-19 pandemic and subsequent crisis in the health care system. Minimal surgical procedures must be performed when resources are available, and a preoperative protocol is necessary for safe surgery following pandemic outbreak. Background: From the first case of SARS-CoV-2 infection in Wuhan (China), the infection spread all around the world causing a pandemic of coronavirus disease-2019 (COVID-19). Spain has been one of the most severely affected countries, and Madrid has reported a high number of cases and deaths. We discuss our strategies for optimal breast cancer management during COVID-19 pandemic. Patients and Methods: This was a retrospective observational study at Clinico San Carlos Hospital to analyze the management of patients with breast cancer during the pandemic outbreak and the surgical strategy after the pandemic outbreak. We created a practical and dynamic tool based on a "traffic light" system for prioritizing surgical time. Every patient was contacted by telephone with a preoperative COVID-19 protocol. After surgical procedures, patient satisfaction was assessed using the European Organisation for Research and Treatment of Cancer in-patient satisfaction with cancer care questionnaire (EORTC IN-PATSAT32). Results: Patients with breast cancer actively treated with surgical procedures were put on a waiting list and received systemic therapy. Telemedicine was used to evaluate any side effects and to avoid unnecessary hospital visits. Surgery was only considered after the pandemic outbreak, and then, only those procedures designed to minimize surgical complications and, therefore, reduce hospital stay. We also measured patients' satisfaction with medical and nursing scales that resulted in a "very good" evaluation tending to "excellent". Conclusion: It is necessary to adapt management of oncology treatment and surgical strategy to optimize resources during the COVID-19 pandemic. Patients' perception of care quality and the degree of patients' satisfaction with health services has potential relevance in the absence of outcome data. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:E128 / E135
页数:8
相关论文
共 21 条
[1]   Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial [J].
Bear, Harry D. ;
Wan, Wen ;
Robidoux, Andre ;
Rubin, Peter ;
Limentani, Steven ;
White, Richard L., Jr. ;
Granfortuna, James ;
Hopkins, Judith O. ;
Oldham, Dwight ;
Rodriguez, Angel ;
Sing, Amy P. .
JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (08) :917-923
[2]   An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32) [J].
Brédart, A ;
Bottomley, A ;
Blazeby, JM ;
Conroy, T ;
Coens, C ;
D'Haese, S ;
Chie, WC ;
Hammerlid, E ;
Arraras, JI ;
Efficace, F ;
Rodary, C ;
Schraub, S ;
Costantini, M ;
Costantini, A ;
Joly, F ;
Sezer, O ;
Razavi, D ;
Mehlitz, M ;
Bielska-Lasota, M ;
Aaronson, NK .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) :2120-2131
[3]  
Cazier JB, 2020, LANCET, V395, P1919, DOI DOI 10.1016/S0140-6736(20)31173-9
[4]   Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic [J].
Curigliano, Giuseppe ;
Cardoso, Maria Joao ;
Poortmans, Philip ;
Gentilini, Oreste ;
Pravettoni, Gabriella ;
Mazzocco, Ketti ;
Houssami, Nehmat ;
Pagani, Olivia ;
Senkus, Elzbieta ;
Cardoso, Fatima .
BREAST, 2020, 52 :8-16
[5]   Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium [J].
Dietz, Jill R. ;
Moran, Meena S. ;
Isakoff, Steven J. ;
Kurtzman, Scott H. ;
Willey, Shawna C. ;
Burstein, Harold J. ;
Bleicher, Richard J. ;
Lyons, Janice A. ;
Sarantou, Terry ;
Baron, Paul L. ;
Stevens, Randy E. ;
Boolbol, Susan K. ;
Anderson, Benjamin O. ;
Shulman, Lawrence N. ;
Gradishar, William J. ;
Monticciolo, Debra L. ;
Plecha, Donna M. ;
Nelson, Heidi ;
Yao, Katharine A. .
BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) :487-497
[6]  
Filipe MD, 2020, CLIN BREAST CANCER
[7]   Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response [J].
Grasselli, Giacomo ;
Pesenti, Antonio ;
Cecconi, Maurizio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1545-1546
[8]   Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study [J].
Iwata, Hiroji ;
Masuda, Norikazu ;
Yamamoto, Yutaka ;
Fujisawa, Tomomi ;
Toyama, Tatsuya ;
Kashiwaba, Masahiro ;
Ohtani, Shoichiro ;
Taira, Naruto ;
Sakai, Takehiko ;
Hasegawa, Yoshie ;
Nakamura, Rikiya ;
Akabane, Hiromitsu ;
Shibahara, Yukiko ;
Sasano, Hironobu ;
Yamaguchi, Takuhiro ;
Sakamaki, Kentaro ;
Bailey, Helen ;
Cherbavaz, Diana B. ;
Jakubowski, Debbie M. ;
Sugiyama, Naoko ;
Chao, Calvin ;
Ohashi, Yasuo .
BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (01) :123-133
[9]   Cancer treatment during COVID-19 pandemic [J].
Jindal, Vishal ;
Sahu, Kamal Kant ;
Gaikazian, Susanna ;
Siddiqui, Ahmad Daniyal ;
Jaiyesimi, Ishmael .
MEDICAL ONCOLOGY, 2020, 37 (07)
[10]   Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China [J].
Liang, Wenhua ;
Guan, Weijie ;
Chen, Ruchong ;
Wang, Wei ;
Li, Jianfu ;
Xu, Ke ;
Li, Caichen ;
Ai, Qing ;
Lu, Weixiang ;
Liang, Hengrui ;
Li, Shiyue ;
He, Jianxing .
LANCET ONCOLOGY, 2020, 21 (03) :335-337